Purification of polysaccharides and ultra pure products resulting therefrom
AU5474298A
Use of moieties for binding to hyaluronan and icam-1
AU4938397A
Methods of elevating amounts of hyaluronan in the human body
CA2208924A1
Sparing paclitaxel by the use of hyaluronan
CA2208916A1
Promotion of wound healing utilizing steroids having reduced deterioroussystemic side effects typical of glucocorticoids, mineralocorticoids andsex steroids
CA2205771A1
Improved delivery of disease modifiers
CA2205692A1
Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation
AU2088897A
Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
ZA9702124B
Methods for cell mobilization using in vivo treatment with hyaluronan (HA).
CA2199756A1
Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
CA2195386A1
Use of moieties for binding to hyaluronan and icam-1
ZA9700210B
Oral administration of effective amunts of forms of hyaluronic acid
CA2194750A1
Methods of elevating amounts of hyaluronan in the human body
CA2193941A1
Use of moieties for binding to hyaluronan and icam-1
CA2193940A1
Methods of elevating amounts of hyaluronan in the human body
CA2193921A1
Oral administration of effective amounts of forms of hyaluronic acid according to various standards
AU7687896A
Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (GAGS)
ZA9608847B
Use of hyaluronan in gene therapy
NZ335259A
Use of nucleotide sequences that express hyaluronan acid receptors in gene therapy
